HUP9900243A2 - Sejtdifferenciálódást befolyásoló hatóanyagok - Google Patents

Sejtdifferenciálódást befolyásoló hatóanyagok

Info

Publication number
HUP9900243A2
HUP9900243A2 HU9900243A HUP9900243A HUP9900243A2 HU P9900243 A2 HUP9900243 A2 HU P9900243A2 HU 9900243 A HU9900243 A HU 9900243A HU P9900243 A HUP9900243 A HU P9900243A HU P9900243 A2 HUP9900243 A2 HU P9900243A2
Authority
HU
Hungary
Prior art keywords
cell differentiation
differentiation agents
agents
cell
differentiation
Prior art date
Application number
HU9900243A
Other languages
English (en)
Hungarian (hu)
Inventor
Bradley Michael John Stringer
Original Assignee
Cellfactors Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9510555.7A external-priority patent/GB9510555D0/en
Priority claimed from GB9522562A external-priority patent/GB2294946A/en
Priority claimed from GBGB9606373.0A external-priority patent/GB9606373D0/en
Application filed by Cellfactors Plc filed Critical Cellfactors Plc
Publication of HUP9900243A2 publication Critical patent/HUP9900243A2/hu

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
HU9900243A 1995-05-24 1996-05-22 Sejtdifferenciálódást befolyásoló hatóanyagok HUP9900243A2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9510555.7A GB9510555D0 (en) 1995-05-24 1995-05-24 Human cell lines
GB9522562A GB2294946A (en) 1994-11-08 1995-11-03 Preparation of human cell-lines of fully-differentiated cells of specific tissue type
GBGB9606373.0A GB9606373D0 (en) 1996-03-26 1996-03-26 Differentiation agents

Publications (1)

Publication Number Publication Date
HUP9900243A2 true HUP9900243A2 (hu) 1999-05-28

Family

ID=27267737

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900243A HUP9900243A2 (hu) 1995-05-24 1996-05-22 Sejtdifferenciálódást befolyásoló hatóanyagok

Country Status (7)

Country Link
EP (1) EP0832187A1 (cs)
JP (1) JPH11505713A (cs)
AU (1) AU5905296A (cs)
CA (1) CA2218817A1 (cs)
CZ (1) CZ365097A3 (cs)
HU (1) HUP9900243A2 (cs)
WO (1) WO1996037601A1 (cs)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL57135A (en) * 1979-04-25 1982-12-31 Abic Project Partnership Method for the determination of a factor or factors which enhances the cortisol metabolism in lymphocytes or leucocytes
EP0383363A3 (en) * 1984-11-29 1990-10-03 Regents Of The University Of Minnesota Use of wound healing agents
CA2064787A1 (en) * 1989-08-11 1991-02-12 Joe E. Springer Dopaminergic neurotrophic factor for treatment of parkinson's disease
WO1991009936A1 (en) * 1989-12-26 1991-07-11 Hana Biologics, Inc. Proliferated neuron progenitor cell product and process
KR950704476A (ko) * 1992-10-28 1995-11-20 브렌드 레이놀즈 생물학적 인자 및 신경 간세포(biological factors and neural stem cells)

Also Published As

Publication number Publication date
WO1996037601B1 (en) 2001-04-12
EP0832187A1 (en) 1998-04-01
AU5905296A (en) 1996-12-11
WO1996037601A1 (en) 1996-11-28
MX9708833A (es) 1998-10-31
JPH11505713A (ja) 1999-05-25
CZ365097A3 (cs) 1998-02-18
CA2218817A1 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
IL125126A (en) Electroconversion cell
GB2302757B (en) Electrochemical cell
HUP9600516A3 (en) Electro-chemical cell
IL124269A (en) Cell confinement structure
GB2299202B (en) Battery
GB9612932D0 (en) Battery controller
EP0854883A4 (en) LOCUS-1 OF ENDOTHELIAL CELLS WITH REGULATED DEVELOPMENT
EP0742430A3 (en) Circulation tank
GB9512529D0 (en) Cell treatment
GB2302622B (en) Battery controller
GB9626775D0 (en) NMR mearsuring cell
IL113641A (en) Electrochemical cell
EP0854941A4 (en) ELECTROCHEMICAL SYSTEM
ZA964368B (en) Attachment enhanced 293 cells
HUP9900243A2 (hu) Sejtdifferenciálódást befolyásoló hatóanyagok
GB9610809D0 (en) Differentiation agents
EP0865090A4 (en) ELECTRODE FOR CELL
GB9508129D0 (en) Cell modification
GB9526578D0 (en) Electrochemical cell
CA76159S (en) Battery
GB9425050D0 (en) Cell line
GB9509810D0 (en) Cell specific expression
GB9508469D0 (en) Cell specific expression
EP0821767A4 (en) RETENTION ELEMENT
GB9520292D0 (en) Kinetomatic battery